Innovations and advancements in modern-day medicine continue to lessen disease burden and contribute to growth in life expectancy. However, despite these advancements, access to and benefits from these opportunities are not always equitable across populations. In the U.S. healthcare system, underserved populations are often left with fewer resources, less attentive care, and limited access to care.

A cancer diagnosis brings many psychosocial implications from diagnosis to remission, but life after active disease is not free of emotional distress. Many cancer survivors are relieved of the immediate distress that develops during a cancer journey, yet 25% of survivors experience persistent psychosocial distress including anxiety and depression.

Distress screening identifies people at risk for mental health concerns like anxiety or depression. For cancer patients, who are at higher risk than the general population for both anxiety and depression, it is especially critical to screen for these concerns. Keep reading to learn how our distress screening program can foster better outcomes for people with cancer and lower healthcare utilization and spending.